Psychotropic drugs and the risk of fractures in old age: a prospective population-based study

Nurminen, Janne; Puustinen, Juha; Piirtola, Maarit; Vahlberg, Tero; Kivelä, Sirkka-Liisa
January 2010
BMC Public Health;2010, Vol. 10, p396
Academic Journal
Background: There is evidence that the use of any psychotropic and the concomitant use of two or more benzodiazepines are related to an increased risk of fractures in old age. However, also controversial results exist. The aim was to describe associations between the use of a psychotropic drug, or the concomitant use of two or more of these drugs and the risk of fractures in a population aged 65 years or over. Methods: This study was a part of a prospective longitudinal population-based study carried out in the municipality of Lieto, South-Western Finland. The objective was to describe gender-specific associations between the use of one psychotropic drug [benzodiazepine (BZD), antipsychotic (AP) or antidepressant (AD)] or the concomitant use of two or more psychotropic drugs and the risk of fractures in a population 65 years or over. Subjects were participants in the first wave of the Lieto study in 1990-1991, and they were followed up until the end of 1996. Information about fractures confirmed with radiology reports in 1,177 subjects (482 men and 695 women) during the follow-up was collected from medical records. Two follow-up periods (three and six years) were used, and previously found risk factors of fractures were adjusted as confounding factors separately for men and women. The Poisson regression model was used in the analyses. Results: The concomitant use of two or more BZDs and the concomitant use of two or more APs were related to an increased risk of fractures during both follow-up periods after adjusting for confounding factors in men. No similar associations were found in women. Conclusions: The concomitant use of several BZDs and that of several APs are associated with an increase in the risk of fractures in older men. Our findings show only risk relations. We cannot draw the conclusion that these drug combinations are causes of fractures.


Related Articles

  • Guidelines for prescribing psychoactive drugs in the elderly: Part 1. Maletta, Gabe; Dysken, Maurice; Mattox, Kimberly M. // Geriatrics;Sep1991, Vol. 46 Issue 9, p40 

    Primary care physicians are usually the first to see elderly patients with emotional problems secondary to dementia and other psychiatric disorders. Because these problems often can be treated effectively, physicians should have a working knowledge of the guidelines for optimal use of...

  • Guidelines for prescribing psychoactive drugs in the elderly: Part 2. Maletta, Gabe; Dysken, Maurice; Mattox, Kimberly M. // Geriatrics;Sep1991, Vol. 46 Issue 9, p52 

    Antipsychotic drugs are frequently used (and sometimes overused) to manage behavioral problems, especially in demented patients. All antipsychotics theoretically work through the same mechanism, so drug selection is based primarily on side effect profiles. In this article, we provide prescribing...

  • Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. Huybrechts, Krista F.; Rothman, Kenneth J.; Silliman, Rebecca A.; Brookhart, Alan; Schneeweiss, Sebastian // CMAJ: Canadian Medical Association Journal;4/19/2011, Vol. 183 Issue 7, pE411 

    Background: Despite safety-related concerns, psychotropic medications are frequently prescribed to manage behavioural symptoms in older adults, particularly those with dementia. We assessed the comparative safety of different classes of psychotropic medications used in nursing home residents....

  • Spotlight on Ziprasidone in Schizophrenia and Schizoaffective Disorder. Gunasekara, N.S.; Spencer, C.M.; Keating, G.M. // CNS Drugs;2002, Vol. 16 Issue 9, p645 

    Ziprasidone is a novel antipsychotic agent with a pharmacological profile distinct from that of other currently available novel or classical antipsychotics. In preclinical studies, ziprasidone was predicted to have efficacy against positive, negative and affective symptoms of schizophrenia with...

  • New study designs for new antipsychotics. Kahn, S. // Psychopharmacology;2002, Vol. 162 Issue 1, p92 

    Focuses on study designs for new antipsychotics. Problems in comparing new with older antipsychotics; Questions which need to be addressed in assessing the new antipsychotics.

  • Expert consensus-based medication-use evaluation criteria for atypical antipsychotic drugs. Love, Raymond C.; Mackowick, Marie; Carpenter, Daniel; Burks, Emalie J. // American Journal of Health-System Pharmacy;12/1/2003, Vol. 60 Issue 23, p2455 

    Focuses on medication-use criteria developed for the appropriate use of atypical antipsychotics through a national consensus process utilizing an expert panel. Demonstration of the utility of a consensus-based process in addressing issues and practices not adequately addressed in the scientific...

  • ANTIPSYCHOTICS AND VENOUS THROMBOSIS: Dutch experience differs. Kleijer, Bart C.; Heerdink, E. R.; Van Marum, R. J. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/16/2010, Vol. 341 Issue 7777, p793 

    A letter to the editor is presented about a case-control study on the use of antipsychotics in elderly patients.

  • Newer psychotropics and the older patient. Arenson, Christine A.; Wender, Richard C. // Patient Care;1/15/1999, Vol. 33 Issue 1, p151 

    Focuses on several psychotropic agents. Rational approach to antidepressant therapy; Neuroleptics; Prescription of neuroleptic therapy.

  • PSYCHOTROPIC DRUG INDICATIONS.  // Monthly Prescribing Reference;Nov2013, Vol. 29 Issue 11, p278 

    The article present a table which lists several psychotropic drugs cateogaries including atypical antipsychotics, selective serotonin reuptake inhibitors and monoamine oxidase inhibitors.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics